<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02439983</url>
  </required_header>
  <id_info>
    <org_study_id>14-PHX-0002</org_study_id>
    <nct_id>NCT02439983</nct_id>
  </id_info>
  <brief_title>Brain Imaging Study</brief_title>
  <official_title>A Randomized, Double-blind, Placebo-controlled Study Investigating the Effects of a Proprietary Nutritional Supplement on Brain Health</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pharmanex</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Pharmanex</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to evaluate the effects of the proprietary nutritional supplement on
      cognition, mood, and brain imaging parameters following a relatively short period of
      treatment.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in MRI Brain scan</measure>
    <time_frame>Change from Baseline MRI Brain scan at Day 42</time_frame>
    <description>Determine differences in brain metabolism, brain connectivity, or brain structure. Highlight regional brain changes between pre and post chronic supplementation with a proprietary nutritional formula.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in anxiety as measured by the Hamilton Anxiety Scale (HAM-A)</measure>
    <time_frame>Change from Baseline anxiety at Day 42</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in depression as measured by the Hamilton Depression Rating Scale (HAM-D)</measure>
    <time_frame>Change from Baseline depression at Day 42</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in mood as measured by the Profile of Mood States (POMS)</measure>
    <time_frame>Change from Baseline mood at Day 42</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in memory as measured by Logical Memory I and II (subtests from the Wechsler Memory Scale- IV)</measure>
    <time_frame>Change from Baseline memory at Day 42</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in fluency as measure by Letter and Category Fluency test</measure>
    <time_frame>Change from Baseline fluency at Day 42</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Chemistry panel</measure>
    <time_frame>Change from Baseline Chemistry panel at Day 42</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in RBC fatty acid profile</measure>
    <time_frame>Change from Baseline RBC fatty acid profile at Day 42</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Gene expression</measure>
    <time_frame>Change from Baseline Gene expression at Day 42</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of polyphenol metabolites in saliva</measure>
    <time_frame>Day 42</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Brain Health</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Proprietary Nutritional Supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Proprietary Nutritional Supplement</intervention_name>
    <description>2 capsules taken by mouth with morning and evening meals.</description>
    <arm_group_label>Proprietary Nutritional Supplement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>2 capsules taken by mouth with morning and evening meals.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Both male and female subjects will be included.

          -  Age between 40-60 years inclusive.

          -  Healthy subjects who, in the opinion of the investigator, are free of any medical
             conditions that might affect study measures.

          -  Eats 1 or fewer servings of fatty fish per week.

          -  BMI &lt; 35

        Exclusion Criteria:

          -  Current or past neurological illness.

          -  Substance abuse or dependence within the prior 60 days.

          -  Current depression (HAMD greater than 20) or anxiety disorder (HAMA greater than 18).

          -  Current or past history of psychiatric disorder.

          -  History of head trauma with loss of consciousness.

          -  Contraindication to brain MRI examination.

          -  Supplementation with Omega 3, fish oil, or other over the counter supplements
             including the other bioactive ingredients in the proprietary nutritional supplement,
             antioxidants and multi-vitamin mineral supplements for the previous 3 months.

          -  Plasma Omega3 Index &gt;5% at screening visit.

          -  Subject has a known allergy or intolerance to any of the ingredients contained in the
             proprietary nutritional supplement or placebo.

          -  Subject is currently pregnant, planning to become pregnant, or is breastfeeding.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Deborah Yurgelun-Todd, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Utah</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Utah - Brain Institute</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 30, 2015</study_first_submitted>
  <study_first_submitted_qc>May 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2015</study_first_posted>
  <last_update_submitted>August 2, 2016</last_update_submitted>
  <last_update_submitted_qc>August 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

